FDA Recalls Cancer Drug After Steel Particles Found In Injectable Medication

Sunny Pharmtech Inc. has voluntarily recalled three lots of Cyclophosphamide for Injection, USP, after discovering steel particulate matter in the injectable cancer drug, prompting a nationwide recall to the user level, according to the U.S. Food and Drug Administration (FDA). The FDA announced the recall on July 24, warning that patients who receive contaminated intravenous […]

The post FDA Recalls Cancer Drug After Steel Particles Found In Injectable Medication appeared first on Dallas Express.